Apixabanum
 |
Cave: notitiae huius paginae nec praescriptiones nec consilia medica sunt. |
| Cognitores | |
|---|---|
| ChemSpider | 8358471 |
| PubChem | 10182969 |
| DrugBank | DB07828 |
| Natura chemica | |
| |
| |
| Formula chemica | C 25H 25N 5O 4 |
| Massa molaris | 459.497 g/mol |
| Natura pharmacologica | |
| Codex ATC | B01AF02 (WHO) |
| Tempus semivitae biologicum | 9-14 h |
| Metabolismus | iecore (hepaticus) CYP3A4, CYP3A5, CYP1A2 et al. |
| Excretio | faecibus: 75%, renibus: 25% |
| Ad usum therapeuticum | |
| Applicatio | per os |
| MedlinePlus | a613032 (Anglice) |
Apixabanum est factoris Xa inhibitor atque substantia anticoagulans in thrombosibus venosis tractandis et fibrillatione atriali[1]. Usus additus embolismorum pulmonum sive providentiae apoplexiae cerebri est.
Natura Apixabani
[recensere | fontem recensere]Natura chemica
[recensere | fontem recensere]Apixabanum est pyrazolopyridinum cum gregibus chemicis lactami et piperidini.
Apixabanum est substratum cytochromatis CYP3A4[2]. Massa molaris est 459.497 g/mol.
Nexus interni
Notae
[recensere | fontem recensere]- ↑ Granger C. B., Alexander J. H., et al. (Sep 2011). "Apixaban Versus Warfarin in Patients With Atrial Fibrillation". New England Journal of Medicine 365 (11): 981-92
- ↑ Apixabani interactionum effectus (Anglice)
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.
Cover photo is available under {{::mainImage.info.license.name || 'Unknown'}} license.
Cover photo is available under {{::mainImage.info.license.name || 'Unknown'}} license.
Credit:
(see original file).
